September 25, 2020 15:17 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Iconic singer SP Balasubrahmanyam passes away | Bihar Polls to be held in three phases from Oct 28, results on Nov 10 | Drug Probe: Rakul Preet Singh appears before NCB | Farmers call for Bharat Bandh protesting against India's two new farm bills | India records 86,052 new COVID-19 cases in 24 hours

Millions of US citizens may have to pay for COVID-19 vaccine despite gov't Plans - Reports

Moscow/Sputnik:  Millions of people in the United States may have to pay for COVID-19 vaccination contrary to the plans of the authorities to make the shots free, as government-funded Medicare health insurance for the elderly does not cover the costs of drugs approved for emergency use, the Wall Street Journal (WSJ) newspaper reported.

India adds 75,083 Covid-19 cases in 24 hours, tally crosses 55 lakh

New Delhi/IBNS: India, which has been battered by the Novel Coronavirus pandemic despite months of lockdown, on Tuesday added 75,083 Covid-19 cases taking the tally of infections beyond 55 lakh.

UN chief: COVID-19 vaccine must be affordable and available to all  

New York: The continuing COVID-19 pandemic continues to top a long list of global concerns, the UN chief told journalists on Wednesday, noting that “the grimmest of milestones” is upon us.

India reports over 92,000 Covid-19 cases, 1,136 deaths in 24 hours

New Delhi/IBNS: India, the worst Covid-19-affected Asian country, on Monday reported 92,071 Covid-19 cases taking the overall tally of infections to cross 48-lakh mark.

Oxford Vaccine trials resume in UK days after pause over volunteer's illness

London/IBNS: Pharmaceutical giant AstraZeneca on Saturday resumed the trials of Covid-19 vaccine in the United Kingdom after a brief halt following a volunteer's illness, media reports said.

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

New Delhi/IBNS: Serum Institute of India (SII) on Thursday paused the trial of Covid-19 vaccine a day after it was served a show-cause notice by the Drugs Controller General of India (DCGI) for not informing the central drug regulator about the pause of study testing in other countries, media reports said.

UNICEF to lead global procurement, supply of COVID vaccines

New York: UN Children’s Fund (UNICEF) will be leading procurement and supply of COVID-19 vaccinations to ensure that all countries have safe, fast and equitable access to initial doses when they are available, the agency announced.

India adds close to 61,000 Covid-19 cases, 848 deaths in 24 hours

New Delhi/IBNS: India, which has been badly-hit by the Novel Coronavirus pandemic, added close to 61,000 fresh infections on Tuesday.

Nasal vaccine against COVID-19 prevents infection in mice: Study

Washignton: Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. 

WHO chief warns against COVID-19 ‘vaccine nationalism’, urges support for fair access

New York: Warning against “vaccine nationalism” in the COVID-19 pandemic, the head of the World Health Organization (WHO) has again underlined the importance of global solidarity in addressing the crisis.

DGCI gives nod for Pneumococcal Polysaccharide Conjugate Vaccine

New Delhi/UNI:  The Drug Controller General of India (DCGI) has given its nod to the first fully indigenously-developed Pneumococcal Polysaccharide Conjugate Vaccine for pneumonia,developed by M/s Serum Institute of India Pvt Ltd, Pune.

Search for COVID-19 vaccine: Novavax announces $1.6 billion funding from US govt's Operation Warp Speed

New York: Novavax, Inc, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, on Tuesday announced that it has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021.

Risky and impossible: India's scientific community on ICMR's claim to produce Covid-19 vaccine by Aug 15

New Delhi/IBNS: India's scientific community has termed the Indian Council of Medical Research (ICMR)'s claim to produce the Covid-19 vaccine by Aug 15 as "risky" and "impossible", a media report said.

Chinese COVID-19 vaccine receives approval for military use

Moscow/Sputnik: A COVID-19 vaccine developed by Chinese biotech company CanSino has been approved to be used exclusively by the Chinese military, the company said in a public statement issued to investors through the Hong Kong Stock Exchange on Monday.